Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

Maija Vahteristo(University of Helsinki), Maarit K. Leinonen(University of Helsinki), Joakim Dillner(Karolinska University Hospital), Ilkka Kalliala(Imperial College London), Pekka Nieminen(University of Helsinki), Tytti Sarkeala(Finnish Cancer Registry), Sirpa Heinävaara(University of Helsinki)
International Journal of Cancer
September 1, 2025
10.1002/ijc.70123
Cited by 3

Related Papers

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
|BMJ|2008|630
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
|Vaccine|2006|545
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
|BMJ|2018|385
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
|Virology|2013|317